1,2-dipalmitoylphosphatidylcholine has been researched along with paclitaxel in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, SV; Straubinger, RM | 1 |
| Ali, S; Janoff, A; Mayhew, E; Minchey, S | 1 |
| Arpicco, S; Brusa, P; Cattel, L; Ceruti, M; Crosasso, P; Dosio, F | 1 |
| Feng, SS; Go, ML; Zhao, L | 1 |
| Feng, SS; Zhao, L | 2 |
| Mu, L; Seow, PH | 1 |
| Banerjee, R; Huilgol, N; Preetha, A | 2 |
| Feng, SS; Kocherginsky, N; Kostetski, I; Zhao, L | 1 |
| Alipour, M; Heney, M; Mugabe, C; Omri, A; Suntres, Z; Th'ng, J; Vergidis, D | 1 |
| Bahadur, D; Banerjee, R; Gogoi, M; Kulshrestha, P | 1 |
| Anderson, KW; Mansour, HM; McGarry, RC; Meenach, SA; Zach Hilt, J | 1 |
| Amjad-Iranagh, S; Modarress, H; Mousavi, SZ; Nademi, Y | 1 |
| Anderson, KW; Hilt, JZ; Mansour, HM; McGarry, RC; Meenach, SA | 1 |
| Banerjee, R; Joshi, KS; Joshi, N; Shirsath, N; Singh, A | 1 |
| Banerjee, R; Dyondi, D; Sarkar, A | 1 |
| Chang, S; Liu, L; Sun, J; Wang, Z; Xu, RX; Yin, M; Zhu, S; Zhu, Y | 1 |
| Chiu, GNC; Liu, Y; Ng, Y; Toh, MR | 1 |
| Ahmed, W; Albed Alhnan, M; Elhissi, A; Jain, M; Najlah, M; Phoenix, DA; Taylor, KMG; Wan, KW | 1 |
| Oliveira, ON; Pereira, AR; Shimizu, FM | 1 |
| Chai, J; Guan, J; Liu, Q; Mao, S; Qin, L; Xue, J; Zhang, X | 1 |
22 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and paclitaxel
| Article | Year |
|---|---|
Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Circular Dichroism; Fluorescence Polarization; Lipid Bilayers; Liposomes; Molecular Conformation; Paclitaxel; X-Ray Diffraction | 1994 |
A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acylation; Bridged-Ring Compounds; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Lipid Bilayers; Paclitaxel; Phosphatidylcholines; Taxoids | 2000 |
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents, Phytogenic; Cholesterol; Drug Carriers; Drug Stability; Female; HT29 Cells; Humans; Liposomes; Mice; Mice, Inbred BALB C; Paclitaxel; Phospholipids; Prodrugs; Solubility; Tumor Cells, Cultured; Water | 2000 |
Investigation of molecular interactions between paclitaxel and DPPC by Langmuir film balance and differential scanning calorimetry.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Drug Interactions; Molecular Structure; Paclitaxel; Surface Properties | 2004 |
Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Kinetics; Membranes, Artificial; Paclitaxel; Phosphatidylethanolamines; Phospholipids; Phosphorylcholine; Thermodynamics | 2005 |
Application of TPGS in polymeric nanoparticulate drug delivery system.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Cell Membrane; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Kinetics; Nanotechnology; Paclitaxel; Polyethylene Glycols; Polymers; Surface Properties; Vitamin E | 2006 |
Effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within the lipid monolayer at the air-water interface.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Air; Cholesterol; Membranes, Artificial; Microscopy, Atomic Force; Paclitaxel; Phospholipids; Spectroscopy, Fourier Transform Infrared; Surface Tension; Water | 2006 |
Comparison of paclitaxel penetration in normal and cancerous cervical model monolayer membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane; Cholesterol; Female; Humans; Lipid Bilayers; Paclitaxel; Sphingomyelins; Uterine Cervical Neoplasms; Uterus | 2006 |
DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Ascorbic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholesterol; Electron Spin Resonance Spectroscopy; Lipid Bilayers; Liposomes; Paclitaxel | 2007 |
Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane Permeability; Drug Combinations; Fatty Alcohols; Female; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Liposomes; Membrane Fluidity; Membranes, Artificial; Models, Biological; Paclitaxel; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Surface-Active Agents; Uterine Cervical Neoplasms | 2007 |
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Drug Delivery Systems; Female; Humans; Liposomes; Paclitaxel; Particle Size; Phosphatidylglycerols; Solubility | 2010 |
In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Cell Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; HeLa Cells; Hot Temperature; Humans; Liposomes; Magnetic Fields; Magnetics; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Phosphatidylglycerols; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2012 |
Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antineoplastic Agents, Phytogenic; Desiccation; Dry Powder Inhalers; Lung Neoplasms; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Surface-Active Agents; Technology, Pharmaceutical | 2013 |
Carbon nanotube-encapsulated drug penetration through the cell membrane: an investigation based on steered molecular dynamics simulation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Cell Membrane Permeability; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Nanocapsules; Nanotubes, Carbon; Paclitaxel; Water | 2013 |
High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Crystallography, X-Ray; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Dry Powder Inhalers; Electric Impedance; Equipment Design; Humans; Lung Neoplasms; Microscopy, Fluorescence; Paclitaxel; Particle Size; Phosphatidylglycerols; Powder Diffraction; Powders; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical; Time Factors | 2014 |
Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Antineoplastic Agents, Phytogenic; Biomimetic Materials; Cell Line, Tumor; Cell Survival; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanospheres; Paclitaxel; Phosphatidylethanolamines; Pulmonary Surfactants; Skin Neoplasms; Vasodilation | 2014 |
Joint Surface-Active Phospholipid-Mimetic Liposomes for Intra-Articular Delivery of Paclitaxel.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Inflammatory Agents; Arthritis; Biomimetic Materials; Diffusion; Injections, Intra-Articular; Liposomes; Nanocapsules; Paclitaxel; Particle Size; Rats; Rats, Wistar; Treatment Outcome | 2015 |
Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Drug Carriers; Drug Liberation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Microbubbles; Ovarian Neoplasms; Oxygen; Paclitaxel; Phosphatidylethanolamines; Ultrasonic Waves | 2016 |
Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Dendrimers; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Humans; Mice, SCID; Nanoparticles; Nanotechnology; Nylons; Ovarian Neoplasms; Paclitaxel; Solubility; Time Factors; Xenograft Model Antitumor Assays | 2015 |
Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Brain Neoplasms; Cell Line, Tumor; Cholesterol; Drug Liberation; Ethanol; Humans; Hydrogen-Ion Concentration; Hydrogenation; Liposomes; Paclitaxel; Particle Size; Phosphatidylcholines; Sonication; Surface Properties | 2018 |
Cholesterol modulates the interaction between paclitaxel and Langmuir monolayers simulating cell membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Cell Membrane; Cholesterol; Membranes, Artificial; Paclitaxel; Sphingomyelins | 2021 |
The influence of a biomimetic pulmonary surfactant modification on the in vivo fate of nanoparticles in the lung.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biomimetics; Lung; Nanoparticles; Paclitaxel; Phospholipids; Pulmonary Surfactants; Surface-Active Agents | 2022 |